Skip to main content
. 2021 Apr 1;98(2):E222–E234. doi: 10.1002/ccd.29674

TABLE 3.

In‐hospital outcomes stratified by timing of insertion of Impella 2.5 and CP in relation to the interventional procedure in patients with cardiogenic shock due to acute myocardial infarction and treated with percutaneous coronary intervention (PCI)

Combined (N = 147) Before (N = 55) During/after (N = 92) p‐value
In‐hospital outcomes
Death 44% (64) 29%16 52% (48) <.01
Life‐threatening or severe bleeding 13%19 7%4 16%15 .11
Number of red blood cell transfusions 2 [5;14] 2 [5;12] 2 [5;14] .58
Device‐related complications 35% (52) 29%16 39% (36) .29
Access‐site bleeding 12%17 11%6 12%11 1
Limb ischemia 15%21 17%9 19%17 .46
Need for endovascular intervention 7%10 7%4 7%1 1
Aortic injury 1%1 0% (0) 1%1 1
Left ventricular perforation 0% (0) 0% (0) 0% (0) NA
Sepsis 30% (42) 31%17 29%25 .85
Acute kidney injurya 53% (70) 38%18 61% (52) .02
Need for renal replacement therapy 27% (38) 21%11 31% (27) .23
Escalation therapyb 19% (27) 17%9 20%18 .68
LVEF at discharge, % 33 [25;42] 33 [25;42] 33 [25;45] .62

Note: In‐hospital outcomes are reported as n (%) or median (interquartile range) as appropriate.

Abbreviation: LVEF, left‐ventricular ejection fraction.

a

Defined as a serum creatinine increase ≥0.3 mg/dl from baseline.

b

Defined as the need for extracorporeal membrane oxygenation, other left ventricular assist device implantation or heart transplant.